Related references
Note: Only part of the references are listed.Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
What Can Be Inferred from the Interruption of the Semagacestat Trial for Treatment of Alzheimer's Disease?
Jeffrey Cummings
BIOLOGICAL PSYCHIATRY (2010)
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Michael Gold et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Stem cells in human neurodegenerative disorders - time for clinical translation?
Olle Lindvall et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
William J. Marks et al.
LANCET NEUROLOGY (2010)
Alzheimer's failure raises questions about disease-modifying strategies
Andy Extance
NATURE REVIEWS DRUG DISCOVERY (2010)
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe
H. H. Feldman et al.
NEUROLOGY (2010)
Beyond Access vs. Protection in Trials of Innovative Therapies
Alex John London et al.
SCIENCE (2010)
Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
Emily S. Sena et al.
PLOS BIOLOGY (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Can Animal Models of Disease Reliably Inform Human Studies?
H. Bart van der Worp et al.
PLOS MEDICINE (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Extending Clinical Equipoise to Phase 1 Trials Involving Patients: Unresolved Problems
James A. Anderson et al.
KENNEDY INSTITUTE OF ETHICS JOURNAL (2010)
Effects of NXY-059 in experimental stroke: an individual animal meta-analysis
P. M. W. Bath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
David B. Henley et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial
Robert C. Green et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Launching Invasive, First-in-Human Trials Against Parkinson's Disease: Ethical Considerations
Jonathan Kimmelman et al.
MOVEMENT DISORDERS (2009)
The scientific and clinical basis for the treatment of Parkinson disease (2009)
C. Warren Olanow et al.
NEUROLOGY (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Survey of the Quality of Experimental Design, Statistical Analysis and Reporting of Research Using Animals
Carol Kilkenny et al.
PLOS ONE (2009)
NEUROSCIENCE Fetal Cells Again?
Constance Holden
SCIENCE (2009)
Good Laboratory Practice Preventing Introduction of Bias at the Bench
Malcolm R. Macleod et al.
STROKE (2009)
Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials
Maria Philip et al.
STROKE (2009)
Treatment success in cancer
Berijamin Djulbegovic et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
A Call for Physiopathological Ethics
Pedro R. Lowenstein
MOLECULAR THERAPY (2008)
Drug administration in animal studies of cardiac arrest does not reflect human clinical experience
Joshua C. Reynolds et al.
RESUSCITATION (2007)
Drug development for CNS disorders: strategies for balancing risk and reducing attrition
Menelas N. Pangalos et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Does random treatment assignment cause harm to research participants?
Cary P. Gross et al.
PLOS MEDICINE (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group
A Kumar et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Evaluation of new treatments in radiation oncology - Are they better than standard treatments?
HP Soares et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
CW Olanow et al.
ANNALS OF NEUROLOGY (2003)
Translation of highly promising basic science research into clinical applications
DG Contopoulos-Ioannidis et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.
CR Freed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
